Effect of Feeding Jejunostomy on Sarcopenia in Patients with Esophageal Cancer

Launched by STEFAN GUTKNECHT · Nov 26, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how the timing of a feeding tube placement affects muscle loss in patients with esophageal cancer. Sarcopenia, which means having less muscle mass, can lead to more health problems, especially for those getting treatment for cancer. In this study, some participants will have a feeding tube inserted during a preliminary surgery to help with staging their cancer, while others will have it placed during their main surgery to remove the esophagus. The researchers want to find out if getting the feeding tube earlier helps reduce muscle loss compared to getting it later.

To be eligible for this trial, participants must be adults aged 18 and older with advanced esophageal cancer that is being treated with the intention to cure it. They should have received the feeding tube either before their cancer treatment or during their main surgery. While the trial is not yet recruiting participants, those who join can expect to be closely monitored to see how the timing of the feeding tube affects their muscle health during their cancer treatment journey.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients aged 18 years and above at the time of diagnosis.
• • Advanced-stage esophageal cancer or cancer of the esophageal junction and treated with curative intent, including neoadjuvant treatment.
• • Patients who received an FJT either before neoadjuvant treatment or during definitive surgery.
• Exclusion Criteria:
• • Insufficient data for analysis
• • Written rejection of general consent